Technology area: Biotechnology & Pharmaceuticals
7 pending office actions • 4 art units • 5 examiners • 0 of 7 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Tempus Al Inc. has 7 pending office actions in Biotechnology & Pharmaceuticals. The matters are assigned among 5 distinct examiners and 4 distinct art units, so prosecution involves multiple examination channels rather than a single technical group.
NEGIN, RUSSELL SCOTT handles 2 pending matters, making that examiner the most concentrated point in the current docket. A coordinated review of those matters may help identify recurring issues, while the remaining matters require attention across the other examiner and art-unit assignments.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 6 (86%) |
| Multi-statute (no §101) | 1 (14%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| NEGIN, RUSSELL SCOTT | 2 | 55.9% | +34.2% |
| BAILEY, STEVEN WILLIAM | 2 | 31.6% | +15.2% |
| NGUYEN, TRI T | 1 | 67.5% | +15.3% |
| NGUYEN, PETER | 1 | — | — |
| ANDERSON-FEARS, KEENAN NEIL | 1 | 15.4% | +37.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16789288 | TARGETED-PANEL TUMOR MUTATIONAL BURDEN CALCULATION SYSTEMS AND METHODS | BAILEY, STEVEN WILLIAM | 55d |
| 18478889 | METHODS AND SYSTEMS FOR DISEASE PHENOTYPING USING MULTIMODAL EHR DATA AND WEAK SUPERVISION | NGUYEN, TRI T | — |
| 18261985 | METHODS AND SYSTEMS FOR mRNA BOUNDARY ANALYSIS IN NEXT GENERATION SEQUENCING | NGUYEN, PETER | — |
| 17800492 | SYSTEMS AND METHODS FOR DETECTING VIRAL DNA FROM SEQUENCING | NEGIN, RUSSELL SCOTT | — |
| 17527657 | METHODS AND SYSTEMS FOR REFINING COPY NUMBER VARIATION IN A LIQUID BIOPSY ASSAY | ANDERSON-FEARS, KEENAN NEIL | — |
| 17323982 | SYSTEMS AND METHODS FOR USING SEQUENCING DATA FOR PATHOGEN DETECTION | NEGIN, RUSSELL SCOTT | — |
| 16945588 | METHODS AND SYSTEMS FOR DETECTING MICROSATELLITE INSTABILITY OF A CANCER IN A LIQUID BIOPSY ASSAY | BAILEY, STEVEN WILLIAM | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16789288 | TARGETED-PANEL TUMOR MUTATIONAL BURDEN CALCULATION SYSTEMS AND METHODS | BAILEY, STEVEN WILLIAM | 55d |
| 18478889 | METHODS AND SYSTEMS FOR DISEASE PHENOTYPING USING MULTIMODAL EHR DATA AND WEAK SUPERVISION | NGUYEN, TRI T | — |
| 17800492 | SYSTEMS AND METHODS FOR DETECTING VIRAL DNA FROM SEQUENCING | NEGIN, RUSSELL SCOTT | — |
| 17527657 | METHODS AND SYSTEMS FOR REFINING COPY NUMBER VARIATION IN A LIQUID BIOPSY ASSAY | ANDERSON-FEARS, KEENAN NEIL | — |
| 17323982 | SYSTEMS AND METHODS FOR USING SEQUENCING DATA FOR PATHOGEN DETECTION | NEGIN, RUSSELL SCOTT | — |
| 16945588 | METHODS AND SYSTEMS FOR DETECTING MICROSATELLITE INSTABILITY OF A CANCER IN A LIQUID BIOPSY ASSAY | BAILEY, STEVEN WILLIAM | — |
| Art Unit | Apps |
|---|---|
| 1687 | 3 |
| 1686 | 2 |
| 2128 | 1 |
| 1685 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18478889 | METHODS AND SYSTEMS FOR DISEASE PHENOTYPING USING MULTIMODAL EHR DATA AND WEAK SUPERVISION | NGUYEN, TRI T | 2128 | §101§103§112 | Non-Final OA | — | Pending | Sep 29, 2023 |
| 18261985 | METHODS AND SYSTEMS FOR mRNA BOUNDARY ANALYSIS IN NEXT GENERATION SEQUENCING | NGUYEN, PETER | 1685 | §101§102§103 | Non-Final OA | — | Pending | Jul 18, 2023 |
| 17800492 | SYSTEMS AND METHODS FOR DETECTING VIRAL DNA FROM SEQUENCING | NEGIN, RUSSELL SCOTT | 1686 | §101§102§103§112 | Non-Final OA | — | Pending | Aug 17, 2022 |
| 17527657 | METHODS AND SYSTEMS FOR REFINING COPY NUMBER VARIATION IN A LIQUID BIOPSY ASSAY | ANDERSON-FEARS, KEENAN NEIL | 1687 | §101DP | Final Rejection | — | Pending | Nov 16, 2021 |
| 17323982 | SYSTEMS AND METHODS FOR USING SEQUENCING DATA FOR PATHOGEN DETECTION | NEGIN, RUSSELL SCOTT | 1686 | §103§112 | Final Rejection | — | Pending | May 18, 2021 |
| 16945588 | METHODS AND SYSTEMS FOR DETECTING MICROSATELLITE INSTABILITY OF A CANCER IN A LIQUID BIOPSY ASSAY | BAILEY, STEVEN WILLIAM | 1687 | §101§112 | Final Rejection | — | Pending | Jul 31, 2020 |
| 16789288 | TARGETED-PANEL TUMOR MUTATIONAL BURDEN CALCULATION SYSTEMS AND METHODS | BAILEY, STEVEN WILLIAM | 1687 | §101§112 | Final Rejection | 55d | Pending | Feb 12, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialTempus Al Inc. has 7 pending office actions as of October 2026, spread across 4 art units and 5 examiners.
Russell Scott Negin has the most, with 2 of Tempus Al Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
